HIV and SIV CTL escape: implications for vaccine design - PubMed (original) (raw)

Review

doi: 10.1038/nri1417.

Affiliations

• PMID: 15286729
• DOI: 10.1038/nri1417

Review

HIV and SIV CTL escape: implications for vaccine design

Philip J R Goulder et al. Nat Rev Immunol. 2004 Aug.

No abstract available

PubMed Disclaimer

Similar articles

• CTL ontogeny and viral escape: implications for HIV-1 vaccine design.
  Yang OO. Yang OO. Trends Immunol. 2004 Mar;25(3):138-42. doi: 10.1016/j.it.2004.01.004. Trends Immunol. 2004. PMID: 15036041 Review. No abstract available.
• HIV CTL escape: at what cost?
  Smith SM. Smith SM. Retrovirology. 2004 May 12;1:8. doi: 10.1186/1742-4690-1-8. Retrovirology. 2004. PMID: 15169568 Free PMC article.
• AIDS. Escape from the immune system.
  Walker BD, Goulder PJ. Walker BD, et al. Nature. 2000 Sep 21;407(6802):313-4. doi: 10.1038/35030283. Nature. 2000. PMID: 11014174 No abstract available.
• New finding on immune response to HIV Tat may contribute to vaccine, treatment.
  James JS. James JS. AIDS Treat News. 2000 Sep 22;(351):4. AIDS Treat News. 2000. PMID: 12173551
• Developing an HIV cytotoxic T-lymphocyte vaccine: issues of CD8 T-cell quantity, quality and location.
  Masopust D. Masopust D. J Intern Med. 2009 Jan;265(1):125-37. doi: 10.1111/j.1365-2796.2008.02054.x. J Intern Med. 2009. PMID: 19093965 Review.

Cited by

• MHC signaling during social communication.
  Ruff JS, Nelson AC, Kubinak JL, Potts WK. Ruff JS, et al. Adv Exp Med Biol. 2012;738:290-313. doi: 10.1007/978-1-4614-1680-7_17. Adv Exp Med Biol. 2012. PMID: 22399386 Free PMC article.
• Lessons in nonhuman primate models for AIDS vaccine research: from minefields to milestones.
  Lifson JD, Haigwood NL. Lifson JD, et al. Cold Spring Harb Perspect Med. 2012 Jun;2(6):a007310. doi: 10.1101/cshperspect.a007310. Cold Spring Harb Perspect Med. 2012. PMID: 22675663 Free PMC article.
• Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model.
  Zhen A, Rezek V, Youn C, Rick J, Lam B, Chang N, Zack J, Kamata M, Kitchen S. Zhen A, et al. J Vis Exp. 2016 Jul 2;(113):54048. doi: 10.3791/54048. J Vis Exp. 2016. PMID: 27404517 Free PMC article.
• Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach.
  Ahammad I, Lira SS. Ahammad I, et al. Int J Biol Macromol. 2020 Nov 1;162:820-837. doi: 10.1016/j.ijbiomac.2020.06.213. Epub 2020 Jun 26. Int J Biol Macromol. 2020. PMID: 32599237 Free PMC article.
• Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection.
  Betts MR, Exley B, Price DA, Bansal A, Camacho ZT, Teaberry V, West SM, Ambrozak DR, Tomaras G, Roederer M, Kilby JM, Tartaglia J, Belshe R, Gao F, Douek DC, Weinhold KJ, Koup RA, Goepfert P, Ferrari G. Betts MR, et al. Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4512-7. doi: 10.1073/pnas.0408773102. Epub 2005 Mar 7. Proc Natl Acad Sci U S A. 2005. PMID: 15753288 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database